EIF4EBP1 and neuroblastoma: To do so, we chose two MYCN-amplified NB cell lines, IMR-32 and Kelly, in which we knocked down MYCN expression by siRNA and examined the impact on EIF4EBP1 mRNA levels by qPCR.